MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker

Multiple targeted therapy for advanced clear-cell renal cell carcinoma (RCC) has substantially improved patient outcome, but complete remission is uncommon and many tumors eventually develop resistance. Mechanistic, preclinical, and early clinical data highlight c-Met / hepatocyte growth factor rece...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Macher-Goeppinger, Stephan, Keith, Martina, Endris, Volker, Penzel, Roland, Tagscherer, Katrin E., Pahernik, Sascha, Hohenfellner, Markus, Gardner, Humphrey, Grüllich, Carsten, Schirmacher, Peter, Roth, Wilfried
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352033/
https://ncbi.nlm.nih.gov/pubmed/27894094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13540
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller